Actively Recruiting
Omic Profile in Autism Spectrum Disorder: From Cellular Level Towards Future Treatments
Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-02-23
100
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an interventional non pharmacological study in pediatric patientis affected by Autism Spectrum Disorder. It ams to create a collection of iPSCs and hiNSCs derived from deeply characterized ASD patients, to omics-characterize the cells, and to study the behavioral pattern of microglia-like cells in the onset of ASD.
CONDITIONS
Official Title
Omic Profile in Autism Spectrum Disorder: From Cellular Level Towards Future Treatments
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Defined ASD diagnosis according to DSM-5 criteria
- Age 3-15 years
- Informed consent signed by the guardians/legal representatives
You will not qualify if you...
- Having a defined genetic diagnosis or clinical presentation strongly suggestive of a syndromic condition, including at least 3 facial anomalies, 1 major or 2 minor malformations, or clinical issues affecting 2 or more systems
- No standardized test to establish diagnosis
- Parents refusing to complete the consent form
- Impossible blood sample collection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Foundation IRCCS Carlo Besta Neurological Institute
Milan, Italy, 20133
Actively Recruiting
Research Team
S
Stefano D'Arrigo, M.D.
CONTACT
S
Sara Bulgheroni
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here